Stay updated on Pembrolizumab in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Glioblastoma Clinical Trial page.

Latest updates to the Pembrolizumab in Glioblastoma Clinical Trial page
- CheckyesterdayChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, signaling a minor update to the page's content or formatting. No core study information, eligibility criteria, or results appear to be affected.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now shows a revision label of v3.6.4, replacing the previous v3.6.3. This reflects a minor page version update.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedRevision: v3.6.3 replaces the previous Revision: v3.6.2 in the page metadata. This reflects a minor update to the page rendering without changing the study data.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page now displays a new Revision: v3.6.2 label, replacing the previous Revision: v3.6.0, indicating a newer page version.SummaryDifference0.1%

- Check58 days agoChange DetectedRecruitment status now indicates that no participants are being sought. New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the treatment header formatting was updated along with a revision tag increment from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check65 days agoChange DetectedThe page revision updated from v3.5.4 to v3.5.5. This represents a small software release and does not change study data or how information is displayed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Glioblastoma Clinical Trial page.